The obesity issue is epidemic in America resulting in a myriad of preventable diseases like diabetes, cardiovascular disease, and cancer resulting often in premature death and contributing to the most costliest health care system in the world at plus 2 trillion dollars annually. 3 The escalating cost of our health care system is a tremendous burden to our society already paying two trillion dollars for the Iraq and Afghanistan wars. Other etiologies for heel pain include trauma, arthritides, overuse injury, foot type, gait abnormalities, masses and tumors. In some cases the etiology is multifactorial.
For the obese patient attempting to lose weight by exercise and caloric restriction, having plantar fasciitis makes the situation almost impossible to lose weight. The podiatric physician is faced with a challenging task of determining a viable treatment plan that gets the obese patient exercising with minimal to no pain.
Fortunately, there are many treatment modalities which may be viable for our obese patients as well as others. Ultrasound treatment is non invasive, easy to apply and comfortable for the patient. The high frequency sound stimulates the local tissues and increases the blood flow to the area alleviating inflammation. 4 Prefabricated and custom orthotics is another treatment recommendation. Studies have shown no significant difference between the orthotics and both have shown to consistently reduce heel pain. 4, 5 Injection therapy is another useful modality that has been used to reduce inflammation in plantar fasciitis. In one study Triamcinolone with Lidocaine proved to be the most effective injection compared to 3 other types of medication and technique types. 6 For short term treatment low dye strapping has been found to be effective reducing plantar fascial pain. 7 As clinicians we observe patients with rigid pes cavus and hyperpronated feet with plantar fasciitis. A study by Zammet and Payne showed that foot orthotics altered rearfoot functioning significantly but couldn't correlate this to symptom reduction for plantar fasciitis patients. 8 In another study, a combination of treatments was found to reduce heel pain. The study showed that for at least 12 weeks temporary custom orthotics and stretching reduced heel pain in patients. 9 Medial arch supports reduced heel pain compared to low dye strapping in another study. Both of these treatment modalities were coupled with 9 ultrasound sessions in combination with 3 weeks of calf muscle stretching. 10 A retrospective study reviewed low dose radiotherapy on 273 patients with plantar fasciitis. They found that there was reduction in heel pain especially in patients 50 years or younger. They could not explain why this occurred but recommended this treatment modality for patients 50 years old or younger in acute cases of plantar fasciitis. Acupuncture and acupoint PC 7 significantly reduced heel pain compared to acupoint LI 4 which is considered to have analgesic properties. There were 27 patients receiving acupuncture to PC 7 and 25 patients in LI 4 patients. Each patient received 5 treatments for 2 weeks. 12 Low frequency electrical stimulation was paired with orthotics and stretching versus patients receiving just orthotics and stretching. The results revealed no significant difference between the 2 groups. However, both patient groups had reduction in heel pain after treatments. 13 Other nonsurgical modalities include the use of radiotherapy, Botox injections, extra-corporeal shockwave therapy, platelet plasma injection and dynamic splinting all demonstrating effective heel pain reduction. [14] [15] [16] [17] [18] This study is unique because it compares one modality against another avoiding a combination of treatments seen in many studies. While combining treatments may be necessary for recalcitrant plantar fasciitis it is unclear which treatment is really reducing heel pain. By isolating each modality, which one will provide the highest pain reduction in patients with plantar fasciitis? This prospective randomized study examines four common treatment modalities: arch support, injection, orthotics and ultrasound for the treatment of plantar fasciitis.
Methods
There were 100 patients diagnosed with plantar fasciitis randomly selected by the research assistant to receive one of 4 treatment modalities: ultrasound, functional rigid orthotics, over the counter arch supports, and injection. Each participant reviewed and signed consent form regarding this study. There were 25 patients in each treatment group. Each patient rated their pre treatment subjective pain rating based on a 0-10 scale. Zero equals no pain and 10 is the most severe pain the patient has ever experienced. After one month of treatment the patients pain rating was recorded for every patient in each group. The ultrasound group received 6 treatments of 5 minutes to the painful heel at a cycle of 1.5 over a 2 week period. The arch support group were instructed to purchase an over the counter arch support to fit their feet. The injection group received one injection of .5ccs of Triamcinolone and 1cc of .5% plain Marcaine into the painful heel. The orthotic group was casted using the Root, et al., method and a biomechanical examination was also performed on each patient. 19 The positive casts and biomechanical measurements were sent to a professional orthotic laboratory for fabrication and the orthotic sent to our office for dispensation. The patient's sex, height, weight and age were recorded. The groups BMI or body mass index average was calculated for each group. The average group height, weight and age were also calculated. The average subjective pain rating was calculated. The number of patients with 0/10 pain rating after treatment was recorded for each group. The number of patients whose subjective pain was reduced after treatment in each group was determined. The average pain rating reduction for each group was calculated by the pre-treatment group average pain and subtracted by the post treatment average pain rating for each group.
Results
There were 62 females and 38 males in this study. The ultrasound group had the highest average pain reduction of 3.97 after treatment and the highest number of patients who had less pain after treatment at 81% or 21/25. The ultrasound group also had the lowest BMI average of 30.20. The orthotic group had the second highest subjective pain reduction average after treatment with 2.92. They had the third highest pain reduction patients with 64% or 17/25. The orthotics group had the highest number of patients who had no pain after treatment at 32% or 8/25. The ultrasound group had the second highest number with 20% or 5/25 after treatment. The orthotic group had the second lowest BMI average with 30.3. The injection group had the third highest pain reduction average after treatment with 2.74. The injection group had the second highest number of patients who improved after treatment with 72% 18/25. They had the second highest BMI average with 32. There were 7% of 2/25 patients who got complete pain relief after injection. The arch support group had the highest average BMI of 32.67. The arch support group had the lowest number of patients with no pain after treatment at 5% or 1/25. There were 9/25 or 35% patients who improved after treatment with arch supports. There were 10 patients who weighed over 300 lbs. Eight of 10 were female and the 2 were males. One male weighed 173 kg. (380 lbs.)
Discussion
Based on the results of this study no one treatment provided complete heel pain relief after treatment. Ultrasound group had the overall highest number of patients who had less pain after treatment at 81% with injection second at 72% and orthotic group at 64%. The arch support had the lowest number with 35%.
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Orthotic treatment had the highest number of patients at 32% who reported no pain after treatment. Whereas, the arch support group had only one patient rate 0/10 pain after treatment. This study implies that some patients will require more than just one treatment modality to eliminate the symptoms of plantar fasciitis. Surprisingly, an over the counter arch support provided some relief in 32% of the patients in the arch support group. Despite its nonspecificity it was still helpful for some patients. Each of the treatment groups average BMI was over 30 indicating that most of the patients were overweight or obese. This study corroborates weight is an important factor in the etiology and treatment of this common foot diagnosis. In 1980 the author reported on a retrospective study of complete fascial release and overall results and complications. 20 There were no patients who weighed over 136 kg. (300 lbs.) in that patient population. The female to male ratio was 2:1 as in this study. The overall patient BMI was less than 30 for the patients who participated in the 1980 study. The CDC regards obesity a national health issue. Furthermore, the number one cause of death in women and men is now myocardial infarction linked to obesity. In this study there were 4 times more women than men ( 8 women to 2 men ) that weighed over 136 kg. (300 lbs.) Trying to lose weight by diet and exercise will be difficult for patients with plantar fasciitis. It will be a greater challenge for those who are over 136 kg. (300 lbs.)
Most of the treatments considered in this study are safe and effective in reducing heel pain. However, extra-articular corticosteroid injections has been implicated in adverse reactions including one death from necrotizing fasciitis, injection site cellulitis, atrophy of the fat pad, and tendon rupture. 21 Kim, et al., reported on a 2.4% incidence of plantar fascial rupture after receiving an average of 2.67 injections. 22 The injections consisted of .5ccs of dexamethasone plus .5ccs of Triamcinolone, and .5ccs of Xylocaine mixed with .5ccs of Marcaine. Thus far, there have been no reported cases of severe complications from Botox ® injections and platelet plasma injections.
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The author begins treatment for most patients with plantar fasciitis using ultrasound treatment, and arch supports initially. If there is residual heel pain, an injection is added to the treatment regimen. If there is still recalcitrant heel pain, orthotics is recommended. In about 87% of the patients diagnosed with plantar fasciitis there is heel pain reduction. Thirteen percent don't improve or worsen after exhaustive conservative treatment and 90% of these patients proceed with complete fascial release with a 98% success rate. This is over 35 years of clinical experience and observation.
This study is unique because only one treatment modality was administered to each patient in their respective groups. Many of the studies used multiple treatment modalities with the treatment being investigated to determine if there was significant pain reduction to plantar fasciitis patients. The combining of treatments may show pain reduction but we cannot ascertain which treatment helped more than the others. The authors study clearly demonstrated that each modality decreased heel pain usually in most patients.
